Pathways is a charitable initiative founded by Frimpong to support young players transitioning out of professional football ...

Raghav Maliah has been appointed Chairman of Investment Banking at Goldman Sachs, signaling a push to strengthen its Asia ...

Brazil’s presidential election in 2026 will be key to unlocking more action in the merger-and-acquisition market, according ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

If the Supreme Court moves forward, it could trigger a 10% to 25% jump in the stock price, said Goldman Sachs Group Inc. analyst James Quigley.

Bristol-Myers Squibb Company (NYSE:BMY) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 10:00 AM ETCompany ParticipantsAdam Lenkowsky - ...

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock’s ...

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock’s ...

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock’s ...

Goldman Sachs raises its recommendation on Bayer to buy from neutral, and lifts its target price to 33 euros from 29.10 euros. Shares jump 4.9% to 26.55 euros. ([email protected]) ...

Goldman Sachs analysts cited a positive risk-reward outlook into the second half of 2025, driven by potential catalysts that could support a re-rating towards their sum-of-the-parts (SOTP) valuation ...